FDA grants full approval to Leqembi, opening up coverage of Alzheimer’s drug by Medicare
For the first time in 20 years, the FDA has bestowed full approval on a drug to treat Alzheimer’s disease, opening …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
